Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review by Mcshane, H, Hatherill, M, Hanekom, W, Evans, T

BCG vaccination of the human newborn induces specific regulatory CD4+ T cells. by Riley, J, Keyser, A, Soares, A, Fletcher, H, Hanekom, W

Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses. by Checkley, A, Wyllie, D, Scriba, T, Golubchik, T, Hill, A, Hanekom, W, McShane, H

P16-05. Upregulation of PD-1 and CTLA-4 on HIV-specific T cells in HIV-infected infants by Hanekom W, Hussey G, Hughes J, de Kock M, Mansoor N, Day C, Nqoko BS

Transcriptional profiling of mycobacterial antigen-induced responses in infants vaccinated with BCG at birth by Fletcher, H, Keyser, A, Bowmaker, M, Sayles, P, Kaplan, G, Hussey, G, Hill, A, Hanekom, W

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations. by Hanekom, W, Dockrell, H, Ottenhoff, T, Doherty, T, Fletcher, H, Mcshane, H, Weichold, F, Hoft, D, Parida, S, Fruth, U

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations by Hanekom, W, Dockrell, H, Ottenhoff, T, Doherty, T, Fletcher, H, McShane, H, Weichold, F, Hoft, D, Parida, S, Fruth, U

Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function. by Dintwe, O, Day, C, Smit, E, Nemes, E, Gray, C, Tameris, M, Mcshane, H, Mahomed, H, Hanekom, W, Scriba, T

The role of clinical symptoms in the diagnosis of intrathoracic tuberculosis in young children by Mcshane, H, Tameris, M, Luabeya, K, Geldenhuys, H, Scriba, T, Hussey, G, Mahomed, H, Landry, B, Hanekom, W, Hatherill, M

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses. by Tameris, M, Geldenhuys, H, Luabeya, A, Smit, E, Hughes, J, Vermaak, S, Hanekom, W, Hatherill, M, Mahomed, H, Mcshane, H, Scriba, T

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses by Tameris, M, Geldenhuys, H, Luabeya, A, Smit, E, Hughes, J, Vermaak, S, Hanekom, W, Hatherill, M, Mahomed, H, McShane, H, Scriba, T

A comparison of IFNgamma detection methods used in tuberculosis vaccine trials. by Beveridge, N, Fletcher, H, Hughes, J, Pathan, A, Scriba, T, Minassian, A, Sander, C, Whelan, K, Dockrell, H, Hill, A, Hanekom, W, Mcshane, H

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. by Tameris, MD, Hatherill, M, Landry, B, Scriba, T, Snowden, M, Lockhart, S, Shea, J, McClain, J, Hussey, G, Hanekom, W, Mahomed, H, McShane, H

Impact of isoniazid preventive therapy on the evaluation of long-term effectiveness of infant MVA85A vaccination by Bunyasi, E, Luabeya, A, Tameris, M, Geldenhuys, H, Mulenga, H, Landry, B, Scriba, T, Schmidt, B, Hanekom, W, Mahomed, H, McShane, H, Hatherill, M

Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study by Andrews, J, Nemes, E, Tameris, M, Landry, B, Mahomed, H, McClain, J, Fletcher, H, Hanekom, W, Wood, R, McShane, H, Scriba, T, Hatherill, M

Risk of disease after isoniazid preventive therapy for mycobacterium tuberculosis exposure in young HIV uninfected children by Mcshane, H, Tameris, M, Luabeya, K, Geldenhuys, H, Scriba, T, Hussey, G, Mahomed, H, Landry, B, Hanekom, W, Hatherill, M, Toefey, A, Hughes, E, Van Schalkwyk, A

HIV transmission dynamics and population-wide drug resistance in rural South Africa by Kemp, SA, Kamelian, K, Cuadros, DF, Cheng, MTK, Okango, E, Hanekom, W, Ndung’u, T, Pillay, D, Bonsall, D, Wong, EB, Tanser, F, Siedner, MJ, Gupta, RK

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response. by Matsumiya, M, Harris, SA, Satti, I, Stockdale, L, Tanner, R, O'Shea, M, Tameris, M, Mahomed, H, Hatherill, M, Scriba, T, Hanekom, W, Mcshane, H, Fletcher, H

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response by Matsumiya, M, Harris, SA, Satti, I, Stockdale, L, Tanner, R, O'Shea, M, Tameris, M, Mahomed, H, Hatherill, M, Scriba, T, Hanekom, W, McShane, H, Fletcher, H

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa. by Hawkridge, T, Scriba, T, Gelderbloem, S, Smit, E, Tameris, M, Moyo, S, Lang, T, Veldsman, A, Hatherill, M, Merwe, L, Fletcher, H, Mahomed, H, Hill, A, Hanekom, W, Hussey, G, Mcshane, H